clorazepate dipotassium has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| André, MC; Antunes, J; Filipe, P; Pacheco, D; Silva, R; Soares de Almeida, LM | 1 |
| Dietrichson, P; Lossius, R; Lunde, PK | 1 |
1 trial(s) available for clorazepate dipotassium and Multiple Sclerosis
| Article | Year |
|---|---|
Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations.
Topics: Adult; Aged; Anti-Anxiety Agents; Brain Diseases; Clorazepate Dipotassium; Female; Humans; Kinetics; Male; Middle Aged; Multiple Sclerosis; Muscle Rigidity; Muscle Spasticity; Nordazepam; Reflex, Stretch | 1985 |
1 other study(ies) available for clorazepate dipotassium and Multiple Sclerosis
| Article | Year |
|---|---|
Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.
Topics: Adult; Amitriptyline; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodiazepines; Carbamazepine; Clorazepate Dipotassium; Drug Eruptions; Eosinophilia; Glatiramer Acetate; Humans; Interferon beta-1a; Interferon-beta; Liver; Male; Multiple Sclerosis; Natalizumab; Peptides; Quinazolines; Thrombocytopenia | 2010 |